Jpmorgan Chase & Co »

Theravance Biopharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $496k 44k 11.24
2023-09-30 $412k 48k 8.63
2023-06-30 $526k 51k 10.35
2023-03-31 $1.8M 163k 10.85
2022-12-31 $2.4M 214k 11.22
2022-06-30 $1.9M 207k 9.06
2022-03-31 $1.7M 173k 9.56
2021-12-31 $2.3M 205k 11.07
2021-03-31 $587k 29k 20.43
2020-12-31 $649k 37k 17.77
2020-09-30 $258k 17k 15.05
2020-06-30 $326k 16k 21.01
2020-03-31 $366k 16k 23.10
2019-12-31 $372k 14k 25.87
2019-09-30 $337k 17k 19.45
2019-06-30 $1.5M 93k 16.10
2019-03-31 $4.5M 200k 22.56
2018-12-31 $3.6M 139k 25.59
2018-09-30 $391k 12k 32.83
2018-06-30 $197k 8.7k 22.64
2018-03-31 $239k 9.9k 24.16
2017-12-31 $287k 10k 28.18
2017-06-30 $1.5M 41k 37.04
2017-03-31 $1.7M 47k 37.04
2016-12-31 $3.4M 91k 37.04
2016-09-30 $1.6M 44k 36.26
2016-06-30 $2.0k 109 18.35
2016-03-31 $2.0k 109 18.35
2015-12-31 $4.0k 260 15.38